Bulut Y., Bektay M. Y.
ANKARA UNIVERSITESI ECZACILIK FAKULTESI DERGISI, cilt.49, sa.1, ss.1-9, 2025 (Scopus, TRDizin)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
49
Sayı:
1
-
Basım Tarihi:
2025
-
Doi Numarası:
10.33483/jfpau.1527228
-
Dergi Adı:
ANKARA UNIVERSITESI ECZACILIK FAKULTESI DERGISI
-
Derginin Tarandığı İndeksler:
Scopus, Central & Eastern European Academic Source (CEEAS), EMBASE, TR DİZİN (ULAKBİM)
-
Sayfa Sayıları:
ss.1-9
-
İstanbul Üniversitesi-Cerrahpaşa Adresli:
Evet
Özet
Objective: Heart failure (HF) is associated with poor outcomes, such as high mortality and hospitalization rates, and impaired quality of life (QoL). Pharmacist participations in a multidisciplinary care team have demonstrated to be beneficial in HF, which includes optimization of guideline-directed medical therapy (GDMT) and medication adjustment, optimizing the transition of care (ToC) and medication reconciliation, and providing patient education. The aim of this literature review is to investigate the impact of pharmacist interventions on HF, with the intention to improve clinical outcomes.
Result and Discussion: Randomized controlled trials evaluating the efficacy of pharmacist intervention in HF patients were reviewed, and 8 randomized controlled trials were included. The pharmacist interventions that were investigated in these studies were medication review, patient counseling, and patient education. The included studies demonstrated that pharmacist interventions may reduce prescribing errors, medication discrepancies, and drug-drug interactions (DDIs). Studies demonstrated that patient counseling and education provided by the pharmacist may improve QoL and patient knowledge in HF. The rest of the outcomes lacked significance. In order to develop this issue further, large-scale randomized controlled trials and large-scale meta-analyses should be conducted involving pharmacist interventions in HF.